Published in IDrugs on June 01, 2007
New antiviral therapies for chronic hepatitis C. Hepatol Int (2010) 1.71
Neuroprotective strategies involving ROS in Alzheimer disease. Free Radic Biol Med (2010) 1.57
Mitochondrial approaches for neuroprotection. Ann N Y Acad Sci (2008) 1.48
Cellular metabolic and autophagic pathways: traffic control by redox signaling. Free Radic Biol Med (2013) 1.46
MitoQ administration prevents endotoxin-induced cardiac dysfunction. Am J Physiol Regul Integr Comp Physiol (2009) 1.17
Mitochondrial quality control and communications with the nucleus are important in maintaining mitochondrial function and cell health. Biochim Biophys Acta (2013) 1.10
Mitochondrial targeting of electron scavenging antioxidants: Regulation of selective oxidation vs random chain reactions. Adv Drug Deliv Rev (2009) 1.09
A suggested role for mitochondria in Noonan syndrome. Biochim Biophys Acta (2009) 0.97
SOD1 and MitoTEMPO partially prevent mitochondrial permeability transition pore opening, necrosis, and mitochondrial apoptosis after ATP depletion recovery. Free Radic Biol Med (2010) 0.95
Mitochondrial electron transport and glycolysis are coupled in articular cartilage. Osteoarthritis Cartilage (2012) 0.94
Mitochondria as a target in treatment. Environ Mol Mutagen (2010) 0.92
Nanopreparations for organelle-specific delivery in cancer. Adv Drug Deliv Rev (2013) 0.90
Temporal responses to intrinsically coupled calcium and zinc dyshomeostasis in cardiac myocytes and mitochondria during aldosteronism. Am J Physiol Heart Circ Physiol (2009) 0.90
Bioenergetic effects of mitochondrial-targeted coenzyme Q analogs in endothelial cells. J Pharmacol Exp Ther (2012) 0.89
Metabolic Dysfunctions in Amyotrophic Lateral Sclerosis Pathogenesis and Potential Metabolic Treatments. Front Neurosci (2017) 0.86
Mitochondrial targeted coenzyme Q, superoxide, and fuel selectivity in endothelial cells. PLoS One (2009) 0.85
Novel therapeutics for Alzheimer's disease: an update. Curr Opin Drug Discov Devel (2010) 0.84
Mitochondrial dysfunction: different routes to Alzheimer's disease therapy. Oxid Med Cell Longev (2014) 0.82
Neuronal failure in Alzheimer's disease: a view through the oxidative stress looking-glass. Neurosci Bull (2014) 0.81
Mitochondrial DNA sequence associations with dementia and amyloid-β in elderly African Americans. Neurobiol Aging (2013) 0.81
The regulation of coenzyme q biosynthesis in eukaryotic cells: all that yeast can tell us. Mol Syndromol (2014) 0.81
Multifunctional antioxidants for the treatment of age-related diseases. J Med Chem (2010) 0.80
Genetic inactivation of mitochondria-targeted redox enzyme p66ShcA preserves neuronal viability and mitochondrial integrity in response to oxidative challenges. Front Physiol (2012) 0.78
Nanotechnology inspired tools for mitochondrial dysfunction related diseases. Adv Drug Deliv Rev (2016) 0.78
Still debating a cause and diagnostic criteria for Alzheimer's disease. J Cell Mol Med (2007) 0.78
A new chiral pyrrolyl α-nitronyl nitroxide radical attenuates β-amyloid deposition and rescues memory deficits in a mouse model of Alzheimer disease. Neurotherapeutics (2013) 0.77
Mitochondrial Drugs for Alzheimer Disease. Pharmaceuticals (Basel) (2009) 0.76
Formation and Biological Targets of Quinones: Cytotoxic versus Cytoprotective Effects. Chem Res Toxicol (2016) 0.75
Gene therapy targeting mitochondrial pathway in Parkinson's disease. J Neural Transm (Vienna) (2016) 0.75
Development of hydroxybenzoic-based platforms as a solution to deliver dietary antioxidants to mitochondria. Sci Rep (2017) 0.75